Acrivon Therapeutics, Inc. · 1 day ago
Executive Director/Vice President, Biostatistics
Acrivon Therapeutics is a clinical stage biopharmaceutical company focused on precision medicines through its Generative Phosphoproteomics AP3 platform. They are seeking an experienced Executive Director/Vice President of Biostatistics to lead biostatistics efforts in clinical and diagnostics development, ensuring robust methodology and compliance with regulatory standards.
BiotechnologyHealth CareOncologyTherapeutics
Responsibilities
Work closely with CRO statisticians in the design, protocol development, statistical analysis plan development, and interpretation of exploratory and pivotal drug studies, ensuring robust methodology and compliance with regulatory standards
Work closely with diagnostic partner statisticians in the design, protocol development, statistical analysis plan development, and interpretation of critical studies. These include development, verification and validation studies, ensuring robust methodology and compliance with QSR requirements
Align biostatistics strategy and activities with cross-functional Acrivon teams
Support close interactions with other line functions including research, clinical development, biomarker development, data science, regulatory affairs, and quality
Model and analyze critical data sets from both clinical and diagnostic development studies to support real-time decision making and evolution of strategy. This is a hands-on process
Support FDA submissions and attend FDA meetings, providing the (often substantial) required biostatistics contributions
Qualification
Required
PhD in biostatistics, statistics, mathematics, or related field
8-10 years' experience in biostatistics for clinical and diagnostic development, with companion diagnostic experience required
Solid knowledge of statistical methods underlying diagnostic and clinical development and validation studies, including mixed effects regression modeling, DOEs, binomial modeling, stability models, time-to-event models, bootstrapping, tests for association in categorical variables, etc
Skill in practical application of statistical methods, with extensive experience in R or SAS
Knowledge of the drug and diagnostics co-development process, particularly for companion diagnostics
Excellent strategic thinking and problem-solving skills
Demonstrated ability to work effectively in a collaborative, fast-paced team environment
Strong communication and interpersonal skills, proficient in presenting scientific data and strategies to stakeholders including non-scientific audiences
Company
Acrivon Therapeutics, Inc.
Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform.
H1B Sponsorship
Acrivon Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
Funding
Current Stage
Public CompanyTotal Funding
$245.5MKey Investors
Surveyor Capital,Wellington Management
2024-04-09Post Ipo Equity· $130M
2022-11-15IPO
2021-11-11Series B· $100M
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase